WASHINGTON--(BUSINESS WIRE)--Biotechnology Innovation Organization (BIO) President & CEO James C. Greenwood today issued the following statement on the Hatch-Waxman Integrity Act of 2018: “For almost ...
Washington, D.C. (March 9, 2016) –Biotechnology Innovation Organization (BIO) Executive Vice President for Health Policy Dan Durham released the following statement regarding yesterday's proposed Part ...
Washington, D.C. (March 22, 2010) - Biotechnology Industry Organization (BIO) President and CEO Jim Greenwood released the following statement after passage of "The Patient Protection and Affordable ...
WASHINGTON--The Biotechnology Industry Organization (BIO) applauds Senator Robert Menendez (D-NJ) for introducing the "The Extension of the Therapeutic Discovery Project Tax Credit" (S. 3232), which ...
WASHINGTON--(BUSINESS WIRE)--BIO President and CEO Jim Greenwood issued the following statement regarding today’s proposed changes to Medicare Part D and Medicare Advantage plans: “Today’s proposed ...
Washington, D.C. (October 4, 2015) – Biotechnology Industry Organization (BIO) President and CEO Jim Greenwood released the following statement today: "We are very disappointed in reports from Atlanta ...
DAVIS, Calif., Jan. 05, 2021 (GLOBE NEWSWIRE) -- Marrone Bio Innovations, Inc. (Nasdaq: MBII) (MBI), a leading provider of effective and environmentally responsible pest management and plant health ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback